TEST:

Parsortix Liquid Biopsy

Combination of CTC and ctDNA liquid biopsy for ongoing monitoring of cancer status should become the gold standard once more CTC assays come on stream (for example those being developed by Angle PLC @Parsortix for ovarian cancer, prostate cancer etc) (@Neil_Robinson64)

https://t.co/qMfaThFYpu Hi Massimo as I'm sure your aware angle plc who own the parsortix system gained fda clearance 25/5/22 for the capture of ctc in mbc with recent best in class results for its use in predicting ovarian cancer, had to correct the slide but I'm sure you knew ()

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix®️PC1 System - a FDA approved technology for liquid biopsy #metastaticbreastcancer https://t.co/MINLxt5IA2 ()

@Parsortix @fda approved liquid biopsy test for live CTCs in #mbc #BreastCancer #AGL ()

@Parsortix #agl already have FDA approval for metastatic breast cancer, excellent results for their ovarian study, with prostate here in UK and US to start. World first liquid biopsy for live CTCs with FDA approval ()

RNA-based Algorithm Successfully Predicts Ovarian Cancers in Pelvic Mass https://t.co/4WP382eysq via @clinicalomics @WilmotCancer @Parsortix #ovariancancer #AGL ()

@guardian @guardianscience @guardiantech @Parsortix received @FDA approval on 25May for #Parsortix to be used to for #breastcancer diagnosis, testing etc . It finds LIVE cancer cells - huge benefits vs @GrailBio #AGL https://t.co/KZjvIHoNGB ()

#AGL @Parsortix system has been peer reviewed for tests with many cancers. Inc #ovariancancer #ProstateCancer #lungcancer #bowelcancer #cervicalcancer Should be seen as gold standard & huge story. Needs media, @NHSuk @sajidjavid Should get behind British success ()

Something that may be of interest... @BenStiller @stephenfry @JohnKerry @rodstewart @RobertDeNiroSr @sidneypoitier @AndrewLloydWebb #AGL @Parsortix #prostatecancer ()

Congratulations to ANGLE for FDA approval of the Parsortix® for capture and harvest of circulating tumor cells (CTCs) from metastatic breast cancer for subsequent analysis of liquid biopsies. Proud to have collaborated with this team. https://t.co/lK5WIbcb2j ()

@Parsortix #Angle - @ProstateUK funds new study using Parsortix Huge news with huge potential. "If our hypothesis is correct, we hope that this blood test will become the future standard of care for these patients." #AGL #prostatecancer https://t.co/sd3xfbMvyo #voxmarkets ()